Chelsea Love is a pharmacist who is specialized in Ambulatory Care in Wichita, Kansas. Patients can reach her at 9211 E 21st St N, Wichita or contact her on 316-609-4501. Active license number of Chelsea Love is 1100846 for Ambulatory Care in Kansas. Chelsea Love is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
Chelsea Love speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Chelsea Love
Specialization:
Ambulatory Care
Gender:
Female
Location:
9211 E 21st St N, Wichita, Kansas, 67206-2900
Phone:
316-609-4501
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Chelsea Love are as mentioned below.
NPI Number:
1710569611
NPI Enumeration Date:
21 Apr, 2021
NPI Last Update On:
21 Apr, 2021
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Chelsea Love are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
1100846
Kansas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1209 N Westview Dr, Derby, Kansas
Zip:
67037-2712
Phone Number:
--
Fax Number:
--
Patients can reach Chelsea Love at 9211 E 21st St N, Wichita, Kansas or can call on phone at 316-609-4501.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.